This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Biocryst Pharmaceuticals Inc (BCRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 113.89M 21.16M 20.89M 16.44M
Receivables 9.49M 2.12M 4.56M 7.57M
Inventories n.a. 0.00 0.00 263.00K
Other Current Assets -123.53M 75.00K 0.00 2.30M
Total Current Assets n.a. 42.12M 41.98M 52.86M
Property, Plant & Equipment, Gross n.a. 14.41M 14.93M 14.87M
Accumulated Depreciation & Depletion n.a. 14.11M 14.35M 13.77M
Property, Plant & Equipment, Net n.a. 306.00K 583.00K 1.10M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 136.87M 6.44M 9.84M 28.25M
Total Non-Current Assets 136.87M 6.74M 15.46M 29.35M
Liabilities & Shareholder Equity
Total Assets 136.87M 48.87M 57.44M 82.21M
Accounts Payable n.a. 4.17M 3.97M 2.50M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities n.a. 0.00 0.00 0.00
Total Current Liabilities n.a. 15.26M 17.22M 26.30M
Long Term Debt 30.00M 30.00M 30.00M 30.00M
Deferred Income Taxes n.a. 0.00 0.00 0.00
Other Non-Current Liabilities 31.24M 4.74M 10.67M 11.10M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 61.24M 34.74M 40.67M 41.10M
Total Liabilities 61.24M 49.99M 57.89M 67.40M
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 75.64M -1.13M -454.00K 14.81M
Common Par n.a. 591.00K 509.00K 457.00K
Additional Paid In Capital 0.00 420.99M 391.61M 367.83M
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings -467.90M -422.71M -392.60M -353.52M
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments 543.53M 4.00K 27.00K 40.00K
Total Capitalization 105.64M 28.87M 29.55M 44.81M
Total Equity 75.64M -1.13M -454.00K 14.81M
Total Liabilities & Stock Equity 136.87M 48.87M 57.44M 82.21M
Total Common Shares Outstanding 71.86M 59.09M 50.89M 45.66M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 0.00 0.00 0.00
Basic Weighted Shares Outstanding 66.77M 55.22M 49.47M 45.14M
Diluted Weighted Shares Outstanding 66.77M 55.22M 49.47M 45.14M
Number of Employees NA 40 40 75
Number of Part-Time Employees NA 0 0 0
BCRX News

BCRX Biocryst Pharmaceuticals Inc

Analysts Ratings for BCRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 7 7 8
Moderate Buy 0 1 1 1
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET BCRX ANALYST REPORT

Brokerage Partners

BCRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs